Naoto Okada

12PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Recommender systemsAutoimmunityPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 14, 2026
Active and Non-Active Comparators Yield Different Estimates of the Association Between Proton Pump Inhibitor Use and Recorded Mortality During Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.

|Jan 30, 2026
Impact of immunotherapy on survival and treatment patterns of patients with extensive-stage small cell lung cancer: a study using a Japanese nationwide database.

Yasutaka Ihara, Shoichiro Yamamoto, Megumi Mizutani

|Sep 27, 2025
Changes in the trend and quality of adverse drug reaction reports in the Japanese Adverse Drug Event Report database and the impact of COVID-19-related reports.

Masami Tsuchiya, Takamasa Sakai, Naoto Okada

|Aug 31, 2024
Association between immune checkpoint inhibitor and cytomegalovirus infection: A pharmacovigilance study based on the adverse event reporting system.

Naoto Okada, Tomoyuki Yanagi, Takaaki Sasaki

|Nov 21, 2023
Relationship between prolonged gestation and nifedipine pharmacokinetics in long-term tocolysis.

Miho Tamura, Susumu Murata, Chihiro Ota

|Aug 21, 2023
Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System.

Naoto Okada, Takahiro Niimura, Atsuyuki Saisyo

Pageof 2

Frequent Collaborators

2 joint publications

Shoichiro Yamamoto

2 joint publications

Yasutaka Ihara

1 joint publications

Kenta Yagi

1 joint publications

Masayuki Chuma